Literature DB >> 1701176

Ca2+ potentiates cAMP-dependent expression of urokinase-type plasminogen activator gene through a calmodulin- and protein kinase C-independent mechanism.

A Ziegler1, J Hagmann, B Kiefer, Y Nagamine.   

Abstract

In the porcine renal epithelial cell line, LLC-PK1, activation of the cAMP-dependent signal transduction pathway induces the urokinase-type plasminogen activator (uPA) gene. We show here that the cAMP response is enhanced when the intracellular calcium concentration is increased. When LLC-PK1 cells were treated with the calcium ionophore ionomycin alone, there was no uPA mRNA accumulation. However, in the presence of ionomycin the dose-response of 8-bromo-cAMP (Br-cAMP) with respect to uPA mRNA accumulation was shifted toward the lower concentrations of Br-cAMP. A Northern blot analysis after the inhibition of RNA synthesis and nuclear run-on assays showed that the synergistic effect of Ca2+ could be attributed to increases in uPA gene transcription and mRNA stability. In the presence of cycloheximide, a protein synthesis inhibitor, uPA mRNA was stabilized, but the effect of ionomycin on Br-cAMP-induced mRNA accumulation was still maintained. The result suggests that the Ca2+, at least on transcription, does not require new protein synthesis. Ionomycin treatment did not modify the activity of the cAMP-dependent protein kinase, suggesting that Ca2+ either affects a step in the pathway between the kinase and the uPA gene, or acts independently of the cAMP-dependent protein kinase pathway. The effect of ionomycin was not suppressed by protein kinase C down-regulation nor by inhibitors of calmodulin. Synergism was also observed when Br-cAMP was replaced with calcitonin, a peptide hormone which is coupled to adenylate cyclase, and when ionomycin was replaced with another ionophore A23187, suggesting that the synergism is due to an interaction between cAMP-dependent and Ca2(+)-dependent signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1701176

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  cAMP and Ca²⁺ signaling in secretory epithelia: crosstalk and synergism.

Authors:  Malini Ahuja; Archana Jha; Jozsef Maléth; Seonghee Park; Shmuel Muallem
Journal:  Cell Calcium       Date:  2014-02-07       Impact factor: 6.817

2.  Mutation analysis of very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency: identification and characterization of mutant VLCAD cDNAs from four patients.

Authors:  M Souri; T Aoyama; K Orii; S Yamaguchi; T Hashimoto
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

3.  Cytoplasmic-nuclear shuttling of the urokinase mRNA binding protein regulates message stability.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

4.  Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney.

Authors:  S N Wagner; M J Atkinson; C Wagner; H Höfler; M Schmitt; O Wilhelm
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

5.  Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter.

Authors:  J S Lee; L Catanzariti; B A Hemmings; B Kiefer; Y Nagamine
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

6.  Purification and cDNA cloning of a transcription factor which functionally cooperates within a cAMP regulatory unit in the porcine uPA gene.

Authors:  P A Menoud; R Matthies; J Hofsteenge; Y Nagamine
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

7.  Multiple instability-regulating sites in the 3' untranslated region of the urokinase-type plasminogen activator mRNA.

Authors:  R Nanbu; P A Menoud; Y Nagamine
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

8.  Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells.

Authors:  B R Henderson; R F Kefford
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

9.  Enhanced expression of the urokinase-type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells.

Authors:  N Kondoh; T Yamada; F Kihara-Negishi; M Yamamoto; T Oikawa
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.